We are live on ! Find out more
VBA

Van Berkom & Associates Portfolio holdings

AUM $3.08B
1-Year Est. Return 12.07%
This Fund
S&P 500
This Quarter Est. Return
+6.17%
1 Year Est. Return
+12.07%
3 Year Est. Return
+35.5%
5 Year Est. Return
+48.97%
10 Year Est. Return
+344.82%
AUM
$3.45B
AUM Growth
+$299M
Cap. Flow
+$23.6M
Cap. Flow %
0.68%
Top 10 Hldgs %
32.07%
Holding
62
New
2
Increased
26
Reduced
30
Closed
2

Sector Composition

Rank Sector Weight
1 Industrials 24.41%
2 Consumer Discretionary 16.71%
3 Financials 16.5%
4 Healthcare 11.75%
5 Technology 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRIM icon
26
Primoris Services
PRIM
$4.06B
$68M 1.97%
3,250,146
+587,063
+22% +$12M
MLKN icon
27
MillerKnoll
MLKN
$1.56B
$66.8M 1.93%
1,493,591
-286,052
-16% -$10.8M
AZZ icon
28
AZZ Inc
AZZ
$4.24B
$65M 1.88%
1,412,690
+25,018
+2% +$1.12M
CATM
29
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$64.9M 1.88%
2,376,426
-9,864
-0.4% -$320K
FOXF icon
30
Fox Factory Holding Corp
FOXF
$794M
$64.2M 1.86%
778,137
-212,210
-21% -$15.7M
HLI icon
31
Houlihan Lokey
HLI
$9.72B
$63.1M 1.83%
1,416,322
+1,153,459
+439% +$53.9M
GMED icon
32
Globus Medical
GMED
$11.1B
$62.5M 1.81%
1,476,695
+137,561
+10% +$5.97M
HCSG icon
33
Healthcare Services Group
HCSG
$1.61B
$60.5M 1.75%
1,993,773
+380,175
+24% +$12.6M
TVTY
34
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$57.8M 1.68%
3,517,727
+330,409
+10% +$6.38M
SLCA
35
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$57.4M 1.66%
4,489,754
+795,280
+22% +$10.8M
AMBA icon
36
Ambarella
AMBA
$3.04B
$54.7M 1.58%
1,239,861
-374,552
-23% -$16.8M
RMAX icon
37
RE/MAX Holdings
RMAX
$198M
$53.9M 1.56%
1,751,398
+2,339
+0.1% +$84.1K
STN icon
38
Stantec
STN
$8.17B
$52.9M 1.53%
1,285,503
-522
-0% -$12.6K
SSTK icon
39
Shutterstock
SSTK
$209M
$52.7M 1.53%
1,345,943
-37,224
-3% -$1.54M
UHS icon
40
Universal Health Services
UHS
$10.2B
$51.4M 1.49%
394,462
-1,802
-0.5% -$227K
THO icon
41
Thor Industries
THO
$4.06B
$50.2M 1.45%
859,026
+29,394
+4% +$1.78M
TCX icon
42
Tucows
TCX
$104M
$49M 1.42%
469,523
+45,674
+11% +$3.28M
BC icon
43
Brunswick
BC
$5.23B
$47.4M 1.37%
1,033,524
+1,010,271
+4,345% +$48.8M
WDR
44
DELISTED
Waddell & Reed Financial, Inc.
WDR
$43.2M 1.25%
2,594,388
-11,891
-0.5% -$207K
DXPE icon
45
DXP Enterprises
DXPE
$2.3B
$43.2M 1.25%
1,139,050
-4,927
-0.4% -$189K
ORA icon
46
Ormat Technologies
ORA
$5.8B
$20.4M 0.59%
321,533
+16,214
+5% +$965K
ARA
47
DELISTED
American Renal Associates Holdings, Inc
ARA
$19.8M 0.57%
2,657,010
-32,158
-1% -$212K
FNKO icon
48
Funko
FNKO
$346M
$13.2M 0.38%
+544,268
New +$11.6M
TCOM icon
49
Trip.com Group
TCOM
$29B
$4.39M 0.13%
119,019
+3,968
+3% +$157K
VIPS icon
50
Vipshop
VIPS
$7.26B
$2.95M 0.09%
341,652
+11,402
+3% +$91.9K

Similar funds

Van Berkom & Associates's Q2 2019 Portfolio in Review

As of Q2 2019, Van Berkom & Associates held 62 positions worth $3.45B, up 9.5% from $3.15B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Van Berkom & Associates's Q2 2019 filing shows 2 new, 26 increased, 30 reduced and 2 closed positions. Its largest new stake was Funko: 544,268 shares worth $13.2M. The largest sale was TCF Financial Corporation, an estimated $58.1M.

By sector, the portfolio is most concentrated in Industrials at 24% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Van Berkom & Associates's largest Q2 2019 buy was Funko: 544,268 shares worth $13.2M.
  • Van Berkom & Associates added most to Houlihan Lokey in Q2 2019, an estimated $53.9M increase.
  • Van Berkom & Associates's biggest Q2 2019 reduction was Ambarella, cutting an estimated $16.8M.
  • Van Berkom & Associates fully exited TCF Financial Corporation in Q2 2019, selling an estimated $58.1M.
  • Van Berkom & Associates's ten largest holdings make up 32% of its $3.45B portfolio in Q2 2019.
  • Van Berkom & Associates opened 2 new positions and closed 2 in Q2 2019.
  • Van Berkom & Associates's portfolio value rose 9.5% quarter-over-quarter to $3.45B.

Based on Van Berkom & Associates's 13F filing for Q2 2019, filed 13 Aug 2019.